These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
866 related articles for article (PubMed ID: 15519014)
1. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
2. Dismantling mandates in the treatment of heart failure. Leier CV J Am Coll Cardiol; 2004 Nov; 44(9):1831-3. PubMed ID: 15519015 [No Abstract] [Full Text] [Related]
3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026 [TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114 [TBL] [Abstract][Full Text] [Related]
6. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
7. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927 [TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study. Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919 [TBL] [Abstract][Full Text] [Related]
9. Carvedilol: use in chronic heart failure. Doughty RN; White HD Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454 [TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Khattar RS; Senior R; Soman P; van der Does R; Lahiri A Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363 [TBL] [Abstract][Full Text] [Related]
12. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV Angiology; 2008; 59(3):323-8. PubMed ID: 18388105 [TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure. Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269 [TBL] [Abstract][Full Text] [Related]
14. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086 [TBL] [Abstract][Full Text] [Related]
15. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544 [TBL] [Abstract][Full Text] [Related]
16. Carvedilol reduces aldosterone release in systolic heart failure. Aggarwal A; Wong J; Campbell DJ Heart Lung Circ; 2006 Oct; 15(5):306-9. PubMed ID: 16935558 [TBL] [Abstract][Full Text] [Related]
17. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure. Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934 [TBL] [Abstract][Full Text] [Related]
18. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure. Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865 [TBL] [Abstract][Full Text] [Related]
19. Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure. Fragasso G; Spoladore R; Maranta F; Corti A; Lattuada G; Colombo B; Locatelli M; Salerno A; Calori G; Briceno L; Alfieri AB; Perseghin G; Margonato A J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):49-56. PubMed ID: 23018486 [TBL] [Abstract][Full Text] [Related]
20. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]